Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance (FAT)

March 26, 2018 updated by: Lynsey Wilson, Loughborough University

Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance, Inflammation, Gene Expression and Epigenetic Signatures

The aim of the study is to determine whether fish oil (specifically omega-3 long chain polyunsaturated fatty acids [EPA-DHA]) supplementation can enhance eccentric resistance exercise performance when combined with a resistance exercise training study. The investigators aim to establish the potential mechanisms that might mediate performance changes at a cellular level.

Study Overview

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leicester, United Kingdom, LE11 3TU
        • Loughborough University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Males
  • Healthy

Exclusion Criteria:

  • Resistance exercise training within the past 6 months
  • Vitamin or fish oil supplementation over the past 6 months
  • Habitual use of anti-inflammatory drugs
  • History of heart disease
  • History of coagulation/bleeding disorder
  • History of metabolic disease
  • Serious allergy
  • Known to have blood-borne virus
  • Females (Due to differences in cell membrane incorporation of Omega-3 between the sexes and the testing schedule being unable to fit in with menstrual cycle, altering the blood markers that are being measured)
  • Currently no symptoms of general illness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fish Oil
Fish oil 5.1g/ day - Premium Omega-3, Norwegian Pure-3, Oslo, Norway
Fish Oil Capsule
Other Names:
  • n-3 PUFA, Omega-3
Placebo Comparator: Placebo
Olive Oil 6g/ day - Premium Omega-3, Norwegian Pure-3, Oslo, Norway
Olive Oil capsule manufactured to mimic fish oil capsule
Other Names:
  • Olive Oil

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength
Time Frame: Change from baseline strength at 11 weeks
Quadriceps and Hamstring strength using an isokinetic dynamometer
Change from baseline strength at 11 weeks
Leg power
Time Frame: Change from baseline strength at 11 weeks
Dynamic leg power assessed through jump height on force platform
Change from baseline strength at 11 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

December 20, 2017

Study Completion (Actual)

December 20, 2017

Study Registration Dates

First Submitted

August 4, 2017

First Submitted That Met QC Criteria

August 22, 2017

First Posted (Actual)

August 23, 2017

Study Record Updates

Last Update Posted (Actual)

March 27, 2018

Last Update Submitted That Met QC Criteria

March 26, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LoughboroughU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise-induced Inflammation

Clinical Trials on Fish Oil

3
Subscribe